Role of transoral robotic surgery in the salvage setting: pitfalls and challenges

Abstract

As rates of oropharyngeal squamous cell cancer (OPSCC) increase and patients survive longer, the number of patients with recurrence will also increase. Surgery is the primary tool for the management of locoregional recurrence when feasible, and transoral robotic surgery (TORS) techniques are a useful adjunct in effectively managing these cases. Careful patient selection, surgical planning, a thoughtful reconstructive plan, and postoperative supportive therapy are crucial for adequate oncologic and functional outcomes.

Keywords

Recurrent oropharyngeal cancer / salvage surgery / transoral robotic surgery

References

[1] Mallen-St Clair J, Alani M, Wang MB, Srivatsan ES. Human papillomavirus in oropharyngeal cancer: The changing face of a disease.Biochim Biophys Acta2016;1866:141-50.

[2] Christopherson KM,Elgohari B.Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.Oral Oncol2021;113:105125. PMCID:PMC9272675

[3] Guo T,Ha PK.Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.Cancer2015;121:1977-84 PMCID:PMC4457566

[4] Guo T,Cohen EEW.Current perspectives on recurrent HPV-mediated oropharyngeal cancer.Front Oncol2022;12:966899 PMCID:PMC9433540

[5] The 2011 Oxford CEBM levels of evidence: introductory document. Available from: https://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-Introduction-2.1.pdf [Last accessed on 16 Jan 2024]

[6] Patel SN,Givi B.Salvage surgery for locally recurrent oropharyngeal cancer.Head Neck2016;38 Suppl 1:E658-64

[7] Janot F,Benhamou E.Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.J Clin Oncol2008;26:5518-23.

[8] Paderno A,Bresciani L,Nicolai P.Microvascular head and neck reconstruction after (chemo)radiation: facts and prejudices.Curr Opin Otolaryngol Head Neck Surg2016;24:83-90

[9] White H,Bush B.Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.JAMA Otolaryngol Head Neck Surg2013;139:773-7

[10] Sims JR,Martin EJ.Management of recurrent and metastatic hpv-positive oropharyngeal squamous cell carcinoma after transoral robotic surgery.Otolaryngol Head Neck Surg2017;157:69-76

[11] Dabas S,Ranjan R,Shukla H.Salvage transoral robotic surgery for recurrent or residual head and neck squamous cell carcinoma: a single institution experience.Asian Pac J Cancer Prev2015;16:7627-32

[12] Hardman JC,Brady GC.Transoral robotic surgery for recurrent tumors of the upper aerodigestive tract (RECUT): an international cohort study.J Natl Cancer Inst2022;114:1400-9 PMCID:PMC9552281

[13] Asairinachan A,Fua T,Dixon BJ.Salvage transoral robotic surgery in early-stage oropharyngeal recurrence.Oral Surg Oral Med Oral Pathol Oral Radiol2021;132:18-25

[14] Meulemans J,Vauterin T.Up-front and salvage transoral robotic surgery for head and neck cancer: a belgian multicenter retrospective case series.Front Oncol2017;7:15 PMCID:PMC5298968

[15] D'Andréa G,Nguyen F.A prospective longitudinal study of quality of life in robotic-assisted salvage surgery for oropharyngeal cancer.Eur J Surg Oncol2022;48:1243-50

[16] Gazda P,Chaltiel L.Functional and oncological outcomes of salvage transoral robotic surgery: a comparative study.Eur Arch Otorhinolaryngol2022;279:457-66

[17] Hirshoren N,Fua T,Magarey M.Transoral robotic surgery: implementation as a tool in head and neck surgery - a single-centre Australian experience.ANZ J Surg2018;88:1129-34

[18] Viros Porcuna D,Viña Soria C.Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.Clin Transl Oncol2020;22:1303-11

[19] Isenberg AL,von Buchwald C.Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre.Acta Otolaryngol2020;140:157-62.

[20] Lukens JN,Gamerman V.Late consequential surgical bed soft tissue necrosis in advanced oropharyngeal squamous cell carcinomas treated with transoral robotic surgery and postoperative radiation therapy.Int J Radiat Oncol Biol Phys2014;89:981-8

[21] Hamoir M,Suarez C.The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma.Cancers2018;10:267. PMCID:PMC6115801

[22] Kim J,Albergotti WG.Selection of ideal candidates for surgical salvage of head and neck squamous cell carcinoma: effect of the charlson-age comorbidity index and oncologic characteristics on 1-year survival and hospital course.JAMA Otolaryngol Head Neck Surg2015;141:1059-65 PMCID:PMC4884653

[23] Nguyen AT,Mallen-St Clair J.Comparison of survival after transoral robotic surgery vs nonrobotic surgery in patients with early-stage oropharyngeal squamous cell carcinoma.JAMA Oncol2020;6:1555-62 PMCID:PMC7441465

[24] Nichols AC,Deschler DG.Surgical salvage of the oropharynx after failure of organ-sparing therapy.Head Neck2011;33:516-24.

[25] Joseph AW,Hur K.Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma.Head Neck2016;38 Suppl 1:E1501-9.

[26] Paleri V,Brady G,Kerawala C.Transoral robotic surgery for residual and recurrent oropharyngeal cancers.Otolaryngol Clin North Am2020;53:1091-108

[27] Paleri V,Coward S.Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies.Head Neck2018;40:512-25.

[28] de Almeida JR, Park RC, Villanueva NL, Miles BA, Teng MS, Genden EM. Reconstructive algorithm and classification system for transoral oropharyngeal defects.Head Neck2014;36:934-41

[29] Weinstein GS,Rinaldo A,Werner JA.Understanding contraindications for transoral robotic surgery (TORS) for oropharyngeal cancer.Eur Arch Otorhinolaryngol2015;272:1551-2

[30] Ding X,Zou X.Transoral robotic retropharyngeal lymph node dissection in nasopharyngeal carcinoma with retropharyngeal lymph node recurrence.Laryngoscope2021;131:E1895-902

[31] Avilés-Jurado FX.Transoral reconstruction of oropharyngeal tumors. The Hospital Clínic algorithm.JPRAS Open2020;24:25-31 PMCID:PMC7152593

[32] Genden EM,Tong CC.Transoral robotic resection and reconstruction for head and neck cancer.Laryngoscope2011;121:1668-74

[33] Moore EJ,Kasperbauer JL.Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes.Laryngoscope2009;119:2156-64

[34] Meier JD,Varvares MA.Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey.Head Neck2005;27:952-8

[35] Carey RM,Shimunov D.Locoregional recurrence in p16-positive oropharyngeal squamous cell carcinoma after TORS.Laryngoscope2021;131:E2865-73

[36] Zbären P,Curschmann J.Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas.Head Neck2007;29:26-32.

[37] Sharma A,Baik FM.Survival and gastrostomy prevalence in patients with oropharyngeal cancer treated with transoral robotic surgery vs chemoradiotherapy.JAMA Otolaryngol Head Neck Surg2016;142:691-7 PMCID:PMC6167603

[38] de Rosa N,Silbermins D.Sentinel node biopsy for head and neck melanoma: a systematic review.Otolaryngol Head Neck Surg2011;145:375-82.

[39] Kulcsar MAV,Araujo-Neto VJF,Cernea CR.New method of sentinel lymph node biopsy in transoral robotic surgery for oropharyngeal squamous cell carcinoma.Clinics2018;73:e550s PMCID:PMC6256995

[40] Mastronicola R,Casse A.Current approaches to salvage surgery for head and neck cancer: a comprehensive review.Cancers2023;15:2625 PMCID:PMC10177213

[41] Hatten KM,Weinstein GS.Defining the role of free flaps for transoral robotic surgery.Ann Plast Surg2018;80:45-9.

[42] Microvascular Committee of the American Academy of Otolaryngology-Head & Neck Surgery*. Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach.Head Neck2019;41:16-29.

[43] Gehanno P,Veber F,Alalouf P.Velopharyngeal rehabilitation after transmaxillary buccopharyngectomy extending to the soft palate.Ann Otolaryngol Chir Cervicofac1985;102:135-7

[44] Asairinachan A,Li MP.Facial artery musculomucosal flaps in oropharyngeal reconstruction following salvage transoral robotic surgery: a review of outcomes.J Laryngol Otol2019;133:884-8

[45] Holcomb AJ.Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.Head Neck2021;43:E13-9

[46] Turner MT,Ramadan J.The nasoseptal flap for reconstruction of lateral oropharyngectomy defects: a clinical series.Laryngoscope2022;132:53-60. PMCID:PMC9088552

[47] Chepeha DB,Erickson VR.Oropharyngoplasty with template-based reconstruction of oropharynx defects.Arch Otolaryngol Head Neck Surg2009;135:887-94

[48] Gorphe P,Kolb F.Cervical-transoral robotic oropharyngectomy and thin anterolateral thigh free flap.Eur Ann Otorhinolaryngol Head Neck Dis2018;135:71-4

[49] Hay A,Karassawa Zanoni D.Complications following transoral robotic surgery (TORS): a detailed institutional review of complications.Oral Oncol2017;67:160-6 PMCID:PMC5407467

[50] Rao VUS,R Bhargavi V.Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.Head Neck2021;43:1174-83

[51] Su W,Kang M.Long-term outcomes in patients with recurrent human papillomavirus-positive oropharyngeal cancer after upfront transoral robotic surgery.Head Neck2020;42:3490-6

[52] Jackson RS,Zenga J.Transoral resection of human papillomavirus (hpv)-positive squamous cell carcinoma of the oropharynx: outcomes with and without adjuvant therapy.Ann Surg Oncol2017;24:3494-501 PMCID:PMC9012985

[53] Lee JYK,Stummer W.Review of clinical trials in intraoperative molecular imaging during cancer surgery.J Biomed Opt2019;24:1-8 PMCID:PMC7005471

[54] Nishio N,Martin BA.Photoacoustic molecular imaging for the identification of lymph node metastasis in head and neck cancer using an anti-EGFR antibody-dye conjugate.J Nucl Med2021;62:648-55 PMCID:PMC8844260

[55] De Ravin E,Harmsen S.Indocyanine green fluorescence-guided surgery in head and neck cancer: a systematic review.Am J Otolaryngol2022;43:103570

[56] De Ravin E,Stubbs VC.Second window indocyanine green for oropharyngeal tumours: a case series and comparison of near-infrared camera systems.Clin Otolaryngol2022;47:589-93

[57] Sousa LG,Rodriguez Canales J.ISA101 and nivolumab for HPV-16⁺ cancer: updated clinical efficacy and immune correlates of response.J Immunother Cancer2022;10:e004232 PMCID:PMC9066369

[58] Kang H. NT-I7 for the treatment of recurrent squamous cell carcinoma of head and neck undergoing surgery. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT04588038 [Last accessed on 16 Jan 2024]

[59] Roussey G. Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma (ADJORL1). Available from: https://classic.clinicaltrials.gov/ct2/show/NCT03406247 [Last accessed on 16 Jan 2024]